Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab and Irinotecan in HER2+ Advanced Breast Cancer
NCT00303992Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- May 2004
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in breast cancer, sponsored by University of California, San Francisco. Started May 2004; status: completed.
02
Drugs
irinotecan
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00303992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00303992.